• Cancel
    Date：2025-04

    Exclusive Financial Advisor to IREGENE

  • Cancel
    Date：2025-03
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=873

    Recently, Geneus Technologies, a leading domestic company in nanopore sequencing technology, announced the completion of a nearly RMB 100 million B++ round of financing. This round of funding was led by CDBT Group, with participation from Si Chuan Venture

  • Cancel
    Date：2025-02

    Exclusive Financial Advisor to QL Biopharm

  • Cancel
    Date：2024-10
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=854

    Recently, Dingzhi Dental, a leading brand and expert in complex dental implants in China, announced the closing of its Series A financing, raising several hundred million RMB, with Eight Roads as the sole investor. CEC Capital served as the exclusive

  • Cancel
    Date：2024-10
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=848

    Wuhan-based iRegene, which aims to become a global leader in universal chemically induced cell therapy, recently announced the closing of its Series B financing, raising several hundred million RMB. The round was co-led by Orinno Capital and CDBT Group, w

  • Cancel
    Date：2024-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=842

    MicroCyto announced that it has raised over 300 million yuan in Series A financing. The round was led by Beijing Jingguorui Investment, with participation from Beijing Medical and Health Industry Investment Fund, Shenzhen Capital Group, and Hebei Producti

  • Cancel
    Date：2024-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=839

    MoonBiotech announced that it has recently completed a RMB 300 million Series C+ financing, solely invested by SDIC JULI Investment Management Co., LTD. This financing round follows the Series C funding involving SDIC Venture Capital, marking another inst

  • Cancel
    Date：2024-05
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=775

    Recently, Blue Sail Medical (002382.SZ) announced that its cardiovascular and cerebrovascular business unit, Blue Sail Biosensors, has raised a total of RMB 1 billion in funding. The Series A2 round introduced an additional RMB 100 million, following a RM

  • Cancel
    Date：2024-05

    Exclusive Financial Advisor to MagAssist